Rita Bernhardt
Papers
2
Total Citations
97
H-Index
2
About
Rita Bernhardt is a pioneering figure in steroid biochemistry and biocatalysis, renowned for engineering microbial systems to produce complex human steroid hormones. Her research centers on cytochrome P450 enzymes—specifically steroid hydroxylases—and their application in whole-cell biotransformation. Bernhardt’s major contribution lies in designing an *Escherichia coli* system for whole-cell mediated steroid synthesis, enabling the efficient production of pharmaceutically valuable compounds. Her landmark 2006 paper (62 citations) established a platform for molecular evolution of steroid hydroxylases, while her 2015 work (35 citations) achieved selective cortisol production via a recombinant CYP11B1-dependent *E. coli* biocatalyst, optimized to preparative scale. This breakthrough directly addresses the commercial demand for cortisol, a key anti-inflammatory drug and stress hormone. Bernhardt’s work bridges fundamental enzymology and industrial biotechnology, demonstrating how engineered microbes can replace costly chemical synthesis. Her achievements have profoundly impacted the field, inspiring scalable, sustainable routes to steroid therapeutics. For students and researchers, Bernhardt exemplifies how mechanistic insights into P450 systems can drive real-world biotechnological innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2